期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 9, 期 4, 页码 397-414出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871520610909040397
关键词
Isatin; 2,3-dioxindole; indolinone; cytotoxicity; anticancer; enzyme inhibitor; kinase; tubulin
资金
- University of Wollongong
- URC Small Grant
- University Cancer Research Grant
- Illawarra Cancer Carers Inc.
- Kiama
- Minnamurra
- Gerringong Sunrise Rotary
- Robert East Memorial Fund
Isatin (1H-indole-2,3-dione) and its derivatives demonstrate a diverse array of biological and pharmacological activities including anticonvulsant, antibacterial, antifungal, antiviral and anticancer properties. This broad spectrum of biochemical targets has been facilitated by the synthetic versatility of isatin, which has allowed the generation of a large number of structurally diverse derivatives including analogues derived from substitution of the aryl ring, and/or derivatisation of the isatin nitrogen and C2/C3 carbonyl moieties. The recent FDA approval of the oxindole sunitinib malate, as a kinase inhibitor for the treatment of advanced renal carcinoma and gastrointestinal stromal tumours, underscores the increasing interest in isatins as a new class of antineoplastic agents. In addition to potent kinase inhibition, the mechanism of action of other isatin derivatives includes the inhibition and/or modulation of proteases, translation initiation, neo-vascularisation and tubulin polymerisation. It was therefore the objective of this review to systematically evaluate the cytotoxic and anticancer properties of various substituted isatins and collate these findings to be used as a guide for future structure-activity relationship and mode of action studies. This is the first review to comprehensively discuss the in vitro and in vivo anticancer activities of isatin and its substituted derivatives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据